2 results
Not approvedWill not start
The primary objective of this study is to demonstrate that the IOP-lowering efficacy of Travoprost Ophthalmic Solution, 0.004% (preserved with POLYQUAD) is noninferior to Timolol Ophthalmic Solution (0.5% or 0.25%) in pediatric glaucoma patients.
Approved WMORecruiting
The aim of this study is to determine whether treatment with spinal cord stimulation in patients with refractory angina pectoris leads to a significant reduction in myocardial ischemia. Other aims are to determine the effect of this treatment on the…